Abera Bioscience

Early stage vaccine development company using a platform based on Gram-negative bacteria and derived Outer Membrane Vesicle (OMV) technology.

placeStockholm, Stockholm County, Sweden calendar_todayFounded 2012 groups6 employees language aberabio.com

Social engagement

Social engagement: 2.6K social following, 10 posts in the last 12 months — top quartile of its industry.

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%

Recent activity

18 Jun 2026
Recognition
8 Jun 2026
Milestone
cert
3 Jun 2026
Event
Nasal Drug Delivery Symposium
Coming soon